Related Experiment Video
Updated: Aug 13, 2026

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
Chronic lymphocytic leukaemia presenting with central nervous system involvement
L Poplawska-Szczyglowska1, J Walewski, B Pienkowska-Grela
1Department of Lymphoproliferative Diseases, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Warsaw, Poland.
Insights
This case study highlights a rare, aggressive form of B-cell chronic lymphocytic leukemia (B-CLL). Poor prognostic markers, including bright CD20 expression and trisomy 12, indicated a rapid and fatal disease course.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous lymphoid malignancy.
- Prognostic markers are crucial for predicting disease course and guiding treatment.
- Cerebral involvement in B-CLL can indicate an aggressive presentation.
Observation:
- A 68-year-old male presented with hemiparesis, lymphocytosis, and cerebral lesions.
- Flow cytometry revealed B-CLL lymphocytes with distinct immunophenotypic features: bright CD20 expression, surface immunoglobulin (sIg) positivity, and CD23 antigen negativity.
- Fluorescence in situ hybridization (FISH) detected trisomy 12 in 50% of peripheral mononuclear cells.
Findings:
- The patient exhibited a rapidly progressive and fatal course, succumbing to the disease within 6 months of diagnosis.
- The observed clinical course correlated with the known adverse prognostic significance of bright CD20 expression.
- Trisomy 12 was identified as another poor prognostic indicator in this case.
Implications:
- This case underscores the importance of comprehensive immunophenotyping and cytogenetic analysis in B-CLL diagnosis.
- The combination of bright CD20 and trisomy 12 may predict a particularly aggressive disease phenotype.
- Further research into the molecular mechanisms underlying these poor prognostic markers is warranted to improve therapeutic strategies for high-risk B-CLL patients.
Abstract:
A 68-year-old man presented with hemiparesis, lymphocytosis, and cerebral lesions on MRI. Flow cytometry of blood, bone marrow and cerebrospinal fluid showed B-CLL lymphocytes with bright CD20 expression, sIg, and absence of CD23 antigen. Fluorescence in situ hybridisation showed trisomy 12 in 50% of analysed peripheral mononuclear cells. The patient died 6 months after the diagnosis. Rapidly progressive and fatal course of the disease was consistent with known bad prognostic significance of CD20 bright expression and trisomy 12.
More Related Videos
Related Concept Videos
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction

